
Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …

Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …
Novartis has outlined its long-term strategy for managing a number of key patent expiries. The Swiss-based pharma firm plans to …

